|
C1ORF27 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.122560E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.776200E-03 |
| Normal-vs-Stage2 |
8.937600E-01 |
| Normal-vs-Stage3 |
5.591300E-04 |
| Normal-vs-Stage4 |
2.359600E-04 |
| Stage1-vs-Stage2 |
2.792200E-01 |
| Stage1-vs-Stage3 |
1.544220E-01 |
| Stage1-vs-Stage4 |
9.688100E-02 |
| Stage2-vs-Stage3 |
9.442200E-02 |
| Stage2-vs-Stage4 |
6.462200E-02 |
| Stage3-vs-Stage4 |
7.368800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.737510E-03 |
| Normal-vs-AfricanAmerican |
7.623200E-03 |
| Normal-vs-Asian |
8.133500E-02 |
| Caucasian-vs-AfricanAmerican |
6.913800E-01 |
| Caucasian-vs-Asian |
7.046600E-01 |
| AfricanAmerican-vs-Asian |
7.314600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.60550000000348E-05 |
| Normal-vs-Female |
3.389200E-01 |
| Male-vs-Female |
6.379900E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.832950E-04 |
| Normal-vs-Age(41-60Yrs) |
9.558600E-03 |
| Normal-vs-Age(61-80Yrs) |
1.982160E-03 |
| Normal-vs-Age(81-100Yrs) |
6.677200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.184960E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.633700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.022200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.683000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.692800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.080200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.437800E-01 |
| Normal-vs-Grade 2 |
1.019430E-01 |
| Normal-vs-Grade 3 |
2.237100E-04 |
| Normal-vs-Grade 4 |
1.35099999998278E-06 |
| Grade 1-vs-Grade 2 |
2.313400E-01 |
| Grade 1-vs-Grade 3 |
1.508490E-02 |
| Grade 1-vs-Grade 4 |
9.811500E-04 |
| Grade 2-vs-Grade 3 |
4.418000E-02 |
| Grade 2-vs-Grade 4 |
5.802600E-04 |
| Grade 3-vs-Grade 4 |
4.627800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.463800E-01 |
| Normal-vs-ccB subtype |
1.25300000042294E-07 |
| ccA subtype-vs-ccB subtype |
1.12100000393411E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.485820E-02 |
| Normal-vs-N1 |
5.210600E-01 |
| N0-vs-N1 |
7.915600E-01 |
|
|
